<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report here 3 patients who showed marked improvement of clonic and intentional <z:e sem="disease" ids="C0233651" disease_type="Mental or Behavioral Dysfunction" abbrv="">perseverations</z:e> following the administration of <z:chebi fb="0" ids="2618">amantadine</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Patient 1 had a <z:hpo ids='HP_0011011'>subacute</z:hpo> <z:hpo ids='HP_0002383'>encephalitis</z:hpo> of unknown etiology </plain></SENT>
<SENT sid="2" pm="."><plain>Magnetic resonance imaging documented lesions predominantly in the bilateral putaminal and frontal subcortical areas, and <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography revealed frontal <z:chebi fb="105" ids="17234">glucose</z:chebi> hypometabolism </plain></SENT>
<SENT sid="3" pm="."><plain>Daily <z:chebi fb="0" ids="2619">amantadine hydrochloride</z:chebi> of 200 mg with or without 10 mg of trihexyphenidyl, reduced his clonic and intentional <z:e sem="disease" ids="C0233651" disease_type="Mental or Behavioral Dysfunction" abbrv="">perseverations</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The diagnosis of patients 2 and 3 was vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> with multiple subcortical ischemic lesions, and single <z:chebi fb="23" ids="30212">photon</z:chebi> emission CTs showed reduced cerebral blood flow in the frontal lobes </plain></SENT>
<SENT sid="5" pm="."><plain>Their clonic <z:e sem="disease" ids="C0233651" disease_type="Mental or Behavioral Dysfunction" abbrv="">perseveration</z:e> subsided and intentional <z:e sem="disease" ids="C0233651" disease_type="Mental or Behavioral Dysfunction" abbrv="">perseveration</z:e> disappeared after the administration of 150 mg of daily <z:chebi fb="0" ids="2619">amantadine hydrochloride</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Associated <z:hpo ids='HP_0001300'>Parkinsonism</z:hpo> and <z:e sem="disease" ids="C0009676" disease_type="Mental or Behavioral Dysfunction" abbrv="">confusional state</z:e> also improved in patient 1, but not in patients 2 or 3 </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="2618">Amantadine</z:chebi> increases the pre-synaptic synthesis and release of <z:chebi fb="40" ids="18243">dopamine</z:chebi>, and works as a <z:chebi fb="40" ids="18243">dopamine</z:chebi> system activator </plain></SENT>
<SENT sid="8" pm="."><plain>Our findings suggest that the disturbance of <z:chebi fb="40" ids="18243">dopamine</z:chebi> system, especially meso-limbofrontal projection, has some contributions to the <z:e sem="disease" ids="C0233651" disease_type="Mental or Behavioral Dysfunction" abbrv="">perseveration</z:e> of these patients </plain></SENT>
</text></document>